CG MedTech Co

CG MedTech Co Cash Conversion Cycle

The Cash Conversion Cycle (CCC) of CG MedTech Co (056090.KQ) as of Nov 19, 2026 is 195.57. In the previous year, Cash Conversion Cycle (CCC) was 193.66 — a change of 0.99% (higher).

Cash Conversion Cycle

195.57

YoY

0.99%

Last updated:

Cash Conversion Cycle (CCC) of CG MedTech Co is 2025 195.57 . Cash Conversion Cycle (CCC) of CG MedTech Co was 2024 193.66 . It decreases by 0.99% higher compared to the previous year.

The CG MedTech Co Cash Conversion Cycle history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion Cycle
Date
Cash Conversion Cycle
Jan 1, 2018
301.16 KRW
Jan 1, 2019
329.84 KRW
Jan 1, 2020
220.89 KRW
Jan 1, 2021
233.50 KRW
Jan 1, 2022
223.97 KRW
Jan 1, 2023
219.14 KRW
Jan 1, 2024
193.66 KRW
Jan 1, 2025
195.57 KRW
The CG MedTech Co Cash Conversion Cycle history
YEARCash Conversion CycleYoY
195.57+0.99%
193.66-11.63%
219.14-2.15%
223.97-4.08%
233.50+5.71%
220.89-33.03%
329.84+9.52%
301.16-50.63%
610.04-37.97%
983.40+26.90%
774.96+56.98%
493.67—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd generates revenue through two primary business segments. The Medical Device Business segment produces and sells spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants. These products are sold to healthcare providers and hospitals within the orthopaedic surgical market. The Electric Energy Business segment manufactures and markets electricity meters and integrated calorimeters, targeting utility companies and energy management sectors. Both segments operate under the company's established brand presence in their respective industries. The company's revenue streams are derived from direct sales to end-users in the medical and energy sectors. Orthopaedic surgical implants and devices are purchased by hospitals and clinics specializing in orthopaedic care, while electricity meters and calorimeters are bought by utility providers for infrastructure deployment. The firm's product portfolio is designed to meet specific technical requirements within these specialized markets. CG MedTech Co Ltd's business model focuses on manufacturing high-precision medical devices and energy measurement equipment. The Medical Device Business segment serves the healthcare industry with products for spinal and fracture treatments, while the Electric Energy Business segment supports energy management through metering solutions. This dual-segment approach allows the company to serve two distinct but complementary industrial sectors. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Cash Conversion Cycle (CCC) of CG MedTech Co is 195.57 in 2025.

Cash Conversion Cycle (CCC) of CG MedTech Co changed from 193.66 to 195.57, representing a 0.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Cycle (CCC) CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

The Cash Conversion Cycle measures how long it takes to convert inventory investments into cash from sales. A shorter CCC indicates more efficient working capital management.

CCC = DSO + DIO - DPO

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Cycle (CCC)'s CG MedTech Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Cycle (CCC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Cycle (CCC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — CG MedTech Co

All Key Metrics — CG MedTech Co